Jazz Pharmaceuticals plc EV - Enterprise Value 2011-2026 | JAZZ

Annual EV - Enterprise Value Jazz Pharmaceuticals plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.15 B	6.48 B	6.71 B	7.91 B	7.61 B	8.3 B	10.2 B	9.82 B	11.2 B	9.94 B	8.86 B	11.9 B	9.95 B	3.89 B	2.17 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.9 B	2.17 B	8.27 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Heron Therapeutics HRTX	411 M	$ 0.79	1.9 %	$ 132 M	USA
Altimmune ALT	329 M	$ 3.44	2.99 %	$ 303 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	849 M	$ 218.03	-1.74 %	$ 5 B	Danmark
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Incyte Corporation INCY	18.2 B	$ 90.43	-0.21 %	$ 17.7 B	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Inovio Pharmaceuticals INO	259 M	$ 1.54	-2.41 %	$ 34.1 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	850 M	$ 13.57	7.1 %	$ 818 M	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Inventiva S.A. IVA	129 M	$ 6.07	4.97 %	$ 138 M	France
Calithera Biosciences CALA	916 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
KalVista Pharmaceuticals KALV	639 M	$ 16.82	-1.06 %	$ 835 M	Britain
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	839 M	-	-7.23 %	$ 13 M	USA
Kamada Ltd. KMDA	252 M	$ 8.27	0.24 %	$ 260 M	Israel
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	291 M	$ 2.13	1.67 %	$ 199 M	Israel
Karyopharm Therapeutics KPTI	288 M	$ 7.11	-6.82 %	$ 866 K	USA
Denali Therapeutics DNLI	3.01 B	$ 20.99	4.07 %	$ 3.45 B	USA
Keros Therapeutics KROS	261 M	$ 11.16	1.82 %	$ 415 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	457 M	$ 4.35	2.48 %	$ 722 M	Canada
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA